Ileal apical Na+-dependent bile acid transporter ASBT is upregulated in rats with diabetes mellitus induced by low doses of streptozotocin

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 299, Issue 4, 2010, Pages

  Annaba, Fadi ^a   Ma, Ke ^a   Kumar, Pradeep ^a   Dudeja, Amish K ^a   Kineman, Rhonda D ^a,b   Shneider, Benjamin L ^c   Saksena, Seema ^a   Gill, Ravinder K ^a   Alrefai, Waddah A ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Enterohepatic circulation; Hypercholesterolemia; Insulinopenia

Indexed keywords

APICAL SODIUM DEPENDENT BILE ACID TRANSPORTER; BILE ACID; CHOLESTEROL; HUMAN INSULIN; MEMBRANE PROTEIN; MESSENGER RNA; RNA; SODIUM ION; STREPTOZOCIN; UNCLASSIFIED DRUG; COTRANSPORTER; INSULIN; ORGANIC ANION TRANSPORTER; SODIUM-BILE ACID COTRANSPORTER;

ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; DIABETES MELLITUS; EUTHANASIA; GENE EXPRESSION; HOMEOSTASIS; ILEUM; IN VITRO STUDY; INTESTINE EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SMALL INTESTINE MUCOSA; SPRAGUE DAWLEY RAT; UPREGULATION; WESTERN BLOTTING; ANIMAL; CACO 2 CELL LINE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; EPITHELIUM CELL; EXPERIMENTAL DIABETES MELLITUS; GENETICS; HUMAN; INTESTINE MUCOSA; MALE; METABOLISM; PROMOTER REGION; TOXICITY;

ANIMALS; CACO-2 CELLS; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HUMANS; ILEUM; INSULIN; INTESTINAL MUCOSA; MALE; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; SYMPORTERS; UP-REGULATION;

EID: 77957374576     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00139.2010     Document Type: Article

References (37)

1. Alrefai WA, Gill RK. Bile acid transporters: structure, function, regulation and pathophysiological omplications. Pharm Res 24: 1803-1823, 2007.
2. Bennion LJ, Grundy SM. Effects of diabetes mellitus on cholesterol metabolism in man. N Engl J Med 296: 1365-1371, 1977. (Pubitemid 8127337)
3. Bhat BG, Rapp SR, Beaudry JA, Napawan N, Butteiger DN, Hall KA, Null CL, Luo Y, Keller BT. Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE-/- mice by SC-435. J Lipid Res 44: 1614-1621, 2003. (Pubitemid 37185871)
4. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
5. Brenna O, Qvigstad G, Brenna E, Waldum HL. Cytotoxicity of streptozotocin on neuroendocrine cells of the pancreas and the gut. Dig Dis Sci 48: 906-910, 2003.
6. Caspary WF. Effect of insulin and experimental diabetes mellitus on the digestive-absorptive function of the small intestine. Digestion 9: 248-263, 1973.
7. Caspary WF. Increase of active transport of conjugated bile salts in streptozotocin-diabetic rat small intestine. Gut 14: 949-955, 1973.
8. Chang N, Uribe JM, Keely SJ, Calandrella S, Barrett KE. Insulin and IGF-I inhibit calcium-dependent chloride secretion by T84 human colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 281: G129-G137, 2001.
9. Chen F, Ma L, Al-Ansari N, Shneider B. The role of AP-1 in the transcriptional regulation of the rat apical sodium-dependent bile acid transporter. J Biol Chem 276: 38703-38714, 2001. (Pubitemid 33660217)
10. Chen F, Ma L, Sartor RB, Li F, Xiong H, Sun AQ, Shneider B. Inflammatory-mediated repression of the rat ileal sodium-dependent bile acid transporter by c-fos nuclear translocation. Gastroenterology 123: 2005-2016, 2002.
11. Cohen DE. Balancing cholesterol synthesis and absorption in the gastrointestinal tract. J Clin Lipidol 2: S1-S3, 2008.
12. Dawson PA, Haywood J, Craddock AL, Wilson M, Tietjen M, Kluckman K, Maeda N, Parks JS. Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice. J Biol Chem 278: 33920-33927, 2003.
13. El-Batran SA, Abdel-Salam OM, Nofal SM, Baiuomy AR. Effect of rosiglitazone and nateglinide on serum glucose and lipid profile alone or in combination with the biguanide metformin in diabetic rats. Pharmacol Res 53: 69-74, 2006.
14. Eloranta JJ, Jung D, Kullak-Ublick GA. The human Na+-taurocholate cotransporting polypeptide gene is activated by glucocorticoid receptor and peroxisome proliferator-activated receptor-gamma coactivator-1alpha, and suppressed by bile acids via a small heterodimer partner-dependent mechanism. Mol Endocrinol 20: 65-79, 2006.
15. Fedorak RN, Chang EB, Madara JL, Field M. Intestinal adaptation to diabetes. Altered Na-dependent nutrient absorption in streptozocin-treated chronically diabetic rats. J Clin Invest 79: 1571-1578, 1987. (Pubitemid 17117258)
16. Frankenberg T, Miloh T, Chen FY, Ananthanarayanan M, Sun AQ, Balasubramaniyan N, Arias I, Setchell KD, Suchy FJ, Shneider BL. The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor. Hepatology 48: 1896-1905, 2008.
17. Garber AJ. Attenuating CV risk factors in patients with diabetes: clinical evidence to clinical practice. Diabetes Obes Metab 4, Suppl 1: S5-S12, 2002.
18. Geethan PK, Prince PS. Antihyperlipidemic effect of D-pinitol on streptozotocin- induced diabetic Wistar rats. J Biochem Mol Toxicol 22: 220-224, 2008.
19. Ghosh AK, Lacson R, Liu P, Cichy SB, Danilkovich A, Guo S, Unterman TG. A nucleoprotein complex containing CCAAT/enhancer-binding protein beta interacts with an insulin response sequence in the insulin-like growth factor-binding protein-1 gene and contributes to insulin- regulated gene expression. J Biol Chem 276: 8507-8515, 2001. (Pubitemid 37385665)
20. Hofmann AF. Bile acids: the good, the bad, and the ugly. News Physiol Sci 14: 24-29, 1999.
21. Kim E, Sohn S, Lee M, Jung J, Kineman RD, Park S. Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes. J Endocrinol 188: 263-270, 2006.
22. Kitayama K, Nakai D, Kono K, van der Hoop AG, Kurata H, de Wit EC, Cohen LH, Inaba T, Kohama T. Novel non-systemic inhibitor of ileal apical Na+-dependent bile acid transporter reduces serum cholesterol levels in hamsters and monkeys. Eur J Pharmacol 539: 89-98, 2006.
23. Konrad RJ, Mikolaenko I, Tolar JF, Liu K, Kudlow JE. The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic beta-cell O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase. Biochem J 356: 31-41, 2001.
24. Kullak-Ublick GA, Stieger B, Meier PJ. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 126: 322-342, 2004. (Pubitemid 38040747)
25. Lammert F, Wang DQ. New insights into the genetic regulation of intestinal cholesterol absorption. Gastroenterology 129: 718-734, 2005.
26. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 89: 147-191, 2009.
27. Madsen KL, Ariano D, Fedorak RN. Insulin downregulates diabetic-enhanced intestinal glucose transport rapidly in ileum and slowly in jejunum. Can J Physiol Pharmacol 74: 1294-1301, 1996.
28. McRoberts JA, Riley NE. Role of insulin and insulin-like growth factor receptors in regulation of T84 cell monolayer permeability. Am J Physiol Gastrointest Liver Physiol 267: G883-G891, 1994. (Pubitemid 2163933)
29. Nassir F, Wilson B, Han X, Gross RW, Abumrad NA. CD36 is important for fatty acid and cholesterol uptake by the proximal but not distal intestine. J Biol Chem 282: 19493-19501, 2007. (Pubitemid 47100088)
30. Neimark E, Chen F, Li X, Magid MS, Alasio TM, Frankenberg T, Sinha J, Dawson PA, Shneider BL. c-Fos is a critical mediator of inflammatory-mediated repression of the apical sodium-dependent bile acid transporter. Gastroenterology 131: 554-567, 2006.
31. Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 72: 137-174, 2003.
32. Sarwar Z, Annaba F, Dwivedi A, Saksena S, Gill RK, Alrefai WA. Modulation of ileal apical Na+-dependent bile acid transporter ASBT by protein kinase C. Am J Physiol Gastrointest Liver Physiol 297: G532-G538, 2009.
33. Sonnett TE, Levien TL, Neumiller JJ, Gates BJ, Setter SM. Colesevelam hydrochloride for the treatment of type 2 diabetes mellitus. Clin Ther 31: 245-259, 2009.
34. Staels B, Kuipers F. Bile acid sequestrants and the treatment of type 2 diabetes mellitus. Drugs 67: 1383-1392, 2007.
35. Standaert ML, Bandyopadhyay G, Perez L, Price D, Galloway L, Poklepovic A, Sajan MP, Cenni V, Sirri A, Moscat J, Toker A, Farese RV. Insulin activates protein kinases C-zeta and C-lambda by an autophosphorylation- dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes. J Biol Chem 274: 25308-25316, 1999. (Pubitemid 129530696)
36. Thamotharan M, Bawani SZ, Zhou X, Adibi SA. Hormonal regulation of oligopeptide transporter pept-1 in a human intestinal cell line. Am J Physiol Cell Physiol 276: C821-C826, 1999.
37. van Waarde WM, Verkade HJ, Wolters H, Havinga R, Baller J, Bloks V, Muller M, Sauer PJ, Kuipers F. Differential effects of streptozotocin-induced diabetes on expression of hepatic ABC-transporters in rats. Gastroenterology 122: 1842-1852, 2002.